drugset / Trial / NCT00914290
A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
RandomizedCrossoverDouble-blindTreatment
Summary
To explore the safety and efficacy of IPX056 compared with baclofen tablets for alleviation of symptoms of spasticity associated with multiple sclerosis (MS).
Timeline
- Start
- 2009-04
- Primary completion
- 2010-01
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Baclofen | Small molecule | 5 mg | — |
| Subject | IPX056 | Unknown | 10 mg | — |